New Delhi, July 28 -- Hepatitis, the inflammation of the liver, remains a significant public health concern worldwide. Affecting millions, this condition can arise from several causes, primarily viral infections (Hepatitis A, B, C, D, and E) and non-infectious factors such as alcohol use, drug consumption, and autoimmune disorders. Hepatitis treatment varies depending on the type and cause of the condition. Chronic infections from Hepatitis B (HBV) and C (HCV) pose the most significant risks, potentially leading to serious complications like cirrhosis, liver failure, or even liver cancer if not managed appropriately. However, with advancements in medicine and enhanced public awareness, hepatitis has transitioned from a silent threat to a ...